Couverture vaccinale par le vaccin pneumococcique heptavalent conjugué dans un centre hospitalier de la métropole lilloise en 2008

Prevenar® vaccine coverage evolved well since its universal recommendation achieving a 89.51 % rate for the first dose. The chase of a brought closer follow-up seems important to assess the impact of this new vaccine strategy.